VGM DC Link Blog Home

DME Supplier Impact Survey Strengthens Argument for Reform

Over the past month, VGM Group has been conducting the Supplier Impact Survey in an effort to provide policy makers on Capitol Hill with real-world data on the impacts of the nationwide rollout of competitive bidding and the drastic Medicare reimbursement cuts that have come with it. The survey was open for all suppliers regardless

Read the full article »

Wisconsin Based Provider’s Op-Ed Calling on Leadership to Protect Rural Access

Brian Kelly, vice president of Home Medical Equipment & Infusion Services at Home Health United, Inc. wrote and op-ed in the GazetteXtra, a Janesville, Wisconsin based paper which is the home of Speaker of the House Paul Ryan. In recent months, many VGM Members such as Home Health United have been gaining media attention and

Read the full article »

Most updated results from the Hospital Campaign

We are happy to report that our campaign encouraging hospitals to reach out to their member of Congress about the DME reimbursement concern has completed phase one. 17 hospitals including many of their branch offices have reported sending letters to their members of Congress and Senators. In these letters, hospital administrations express their severe concerns

Read the full article »

Ventilator Bill released, H.R. 6012

Yesterday, Congressman Larry Bucshon (R-IN) introduced the ventilator bill, H.R. 6012. Click here to see the bill language. The Beneficiary Respiratory Equipment Access and Transparency to Home Ventilator Act, a.k.a. Breath Act of 2016 intends to preserves Medicare beneficiary access to ventilators. Specifically, this bill addresses the declining reimbursement rates for home ventilators and establishes

Read the full article »

OIG Report Suggests Infusion Drugs be a part of Competitive Bidding

In a report from OIG to CMS, it was recommended that infusion drugs reflect provider acquisition costs when it comes to Medicare reimbursements. The idea of including DME infusion drugs in the competitive bidding program: Therefore, OIG continues to recommend that: CMS take action to ensure that Medicare payment amounts for DME infusion drugs more

Read the full article »

Op-Ed Outlines Cuts to DME Reimbursements threatens patient access as Congress Returns.

An op-ed in the The Hill on Wednesday evening adds to the continued attention that the DME industry is getting in press outlets with a nationwide audience. The op-ed comes in a timely fashion as Congress has returned from the August recess ready to address the many issues facing the country before they adjourn for

Read the full article »